InsidersTradesSigma
Discover the full record of transactions filed by Michelangelo Stefani, Director. Director active across 1 companies, notably Supersonic Imagine. Cumulatively, 11 disclosures have been logged. Total volume traded: €5.5m. The latest transaction was filed on 27 April 2021 — Acquisition. Regulator: AMF. The full history is accessible without signup.
11 of 11 declarations
Michelangelo Stefani is a medtech executive with a governance-focused profile, identified in SuperSonic Imagine corporate documents as a board director and as the representative of the company’s controlling shareholder, Hologic. In 2020, SuperSonic Imagine’s shareholder materials explicitly named him as the representative of Hologic Hub Ltd. for the annual general meeting, which underlines his role as a key link between the controlling shareholder and the company’s governance structure. Market databases also associate him with several Hologic entities, including Hologic Italia Srl, where he is listed as chairman, and Hologic Ltd., where he has served as a director since 2016. His professional background is rooted in the international medical technology sector, with a particular focus on imaging and diagnostics. Available biographical sources describe him as the former Executive Vice President and Financial Director of SuperSonic Imagine SA and as a former CEO of BK Medical. Taken together, these roles suggest a combination of financial leadership and operational management experience within innovative medtech businesses. That mix typically requires a strong understanding of product development cycles, global commercialization, regulated markets, and capital allocation in companies that depend heavily on R&D and international expansion. At SuperSonic Imagine, his board presence coincided with a strategic period marked by Hologic’s majority ownership and several corporate actions, including shareholder meetings linked to capital structure matters and a proposed listing transfer. In that environment, Michelangelo Stefani appears to have played the role of a governance anchor, helping connect shareholder strategy with the company’s operating and financial priorities. His profile reflects the kind of executive often found in cross-border industrial groups: discreet, highly experienced, and focused on aligning governance, finance, and long-term shareholder value. Overall, Michelangelo Stefani can be positioned as a senior medtech governance executive with broad exposure to international ownership structures, board-level oversight, and the financial steering of specialized medical imaging businesses.